Shares of PTC Inc. PTC shed 4.20% to $142.96 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.37% to 6,556.37 and Dow Jones ...

PTC stock triggered review PTC (PTC) is on the radar after recent trading left the shares about 12% lower year to date. This move has prompted some investors to reassess how the company’s current ...

PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced the appointment of Jessica Chutter to its Board of Directors. Ms. Chutter is a highly accomplished biotechnology investment banker with an ...

What recent performance data suggests about PTC Therapeutics PTC Therapeutics (PTCT) has been moving in different directions ...

PTC is reporting strong efficiency in winning new customers and keeping profitability high. At the same time, annual recurring revenue growth is slower, pointing to rising competition and changing ...

PTC Inc. PTC has unveiled a fully cloud-native Model-Based Definition (MBD) capability integrated directly into its Onshape computer-aided design (CAD) and product data management (PDM) platform. The ...

Divestiture of Kepware Industrial Connectivity and ThingWorx IoT businesses enables PTC to increase focus on Intelligent Product Lifecycle vision Updating post-divestiture ...

WARREN, N.J., Nov. 20, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (PTCT) today announced that it will host an R&D Day to discuss its pipeline on Dec. 2, 2025, at 9:30 a.m. EST in New York City. The ...

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S.